1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow DE-117 Ophthalmic Solution QD: new trials by email Literature Review of DE-117 Ophthalmic Solution QD trials Research Report on DE-117 Ophthalmic Solution QD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 DE-117 Ophthalmic Solution QD, DE-117 Ophthalmic Solution BID - Primary Open-angle Glaucoma and Ocular Hypertension | Phase 2 | Completed | Santen Inc. | 98 | 2019-01-28 | 2020-08-04 |
Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Santen Inc. (1)
United States (1)